NCT00291733View on ClinicalTrials.gov

Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

October 31, 2007

Conditions
Levodopa Induced Dyskinesia
Interventions
DRUG

Levetiracetam

500mg (2 tabl of 250) for one week and 1000mg (4 tabl of 250) for one week

DRUG

Placebo

Placebo tabl

Trial Locations (1)

151-27

Department of Neurology, 1st Hospital of Social Security Services, Athens

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

1st Hospital of Social Security Services

OTHER